Cell morphology, markers, spreading, and proliferation on orthopaedic biomaterials. An innovative cellular model for the "in vitro" study

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 1, 2007, Pages 178-183

  Morelli, Cristina ^a   Barbanti Brodano, Giovanni ^b   Ciannilli, Alessandra ^a   Campioni, Katia ^a   Boriani, Stefano ^b   Tognon, Mauro ^a,c  

^a UNIVERSITY OF FERRARA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Engineered cell; Enhanced green fluorescent protein; Osteoblast molecular marker; Pre clinical characterization

Indexed keywords

BIOMARKERS; CELL ADHESION; CELL PROLIFERATION; MORPHOLOGY; PROTEINS; TISSUE ENGINEERING;

CELLULAR MODEL; HUMAN OSTEOSARCOMA CELL LINE; INNOVATIVE MATERIALS; ORTHOPAEDIC PERSPECTIVE; PROGENITOR CELLS;

BIOMATERIALS;

BIOMATERIAL; CELL MARKER; GREEN FLUORESCENT PROTEIN;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CELL SPREADING; CELL STRUCTURE; IMMUNOFLUORESCENCE; IN VITRO STUDY; ORTHOPEDIC EQUIPMENT; OSTEOBLAST; OSTEOSARCOMA CELL; STEM CELL; TISSUE ENGINEERING;

ACTINS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; BONE SUBSTITUTES; CELL COUNT; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CLONE CELLS; GREEN FLUORESCENT PROTEINS; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; OSTEOPONTIN;

EID: 34548829398     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31262     Document Type: Article

References (14)

1. Langer R, Tirrel DA. Designing materials for biology and medicine. Nature 2004;428:487-492.
2. Wade R, Richardson J. Outcome in fracture healing: A review. Injury 2001;32:109-114.
3. Kokubo T, Kim HM, Kawashita M, Nakamura T. Bioactive metals: Preparation and properties. J Mater Sci Mater Med 2004;15:99-107.
4. Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, Shull S, Mann K, Rodan GA. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res 1987;47:4961-4966.
5. Morelli C, Campioni K, Parolin C, Palu G, Tognon M. Activity of the matrix metalloproteinase 9 promoter in human normal and tumor cells. J Cell Physiol 2004;199:126-133.
6. Cinelli RA, Ferrari A, Pellegrini V, Tyagi M, Giacca M, Beltram F. The enhanced green fluorescent protein as a tool for the analysis of protein dynamics and localization: Local fluorescence study at the single-molecule level. Photochem Photobiol 2000;71:771-776.
7. Shupnik MA, Tashijan AH Jr. Epidemal growth factor and phorbol ester actions on human osteosarcoma cells. J Biol Chem 1982;257:12161-12164.
8. Cormack BP, Valdivia R, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996;173:33-38.
9. Prasher DC, Eckenrode VK, Ward WW, Prendergast FG, Cormier MJ. Primary structure of the Aequorea victoria green fluorescent protein. Gene 1992;111:229-233.
10. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC. Green fluorescent protein as a marker for gene expression. Science 1994;263:802-805.
11. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials 2000;21:667-681.
12. Sinha RK, Tuan RS. Regulation of human osteoblast integrin expression by orthopaedic implant materials. Bone 1996;18:451-457.
13. Ge Z, Baguenard S, Lim LY, Wee A, Khor E. Hydroxyapatite-chitin materials as potential tissue engineered bone substitutes. Biomaterials 2004;25:1049-1058.
14. Xia Z, Ye H, Locklin RM, Ferguson DJ, Cui Z, Triffitt JT. Efficient characterisation of human cell-bioceramic interactions in vitro and in vivo by using enhanced GFP-labelled mesenchymal stem cells. Biomaterials 200526:5790-5800.